Skip to main content
NACFC 2026 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Recorded Session
Recorded Session
Livestreamed Session
Livestreamed Session
Session is Ticketed (Add-on Session through Registration)
Session is Ticketed (Add-on Session through Registration)
Food Available for Session Attendees
Food Available for Session Attendees
Session includes an in person invitee/speaker with CF
Session includes an in person invitee/speaker with CF

Workshop

IMI

W19-- Epidemiology & Clinical Impact of Infection in CF

Friday, October 9, 2026
10:15 AM - 12:15 PM EDT

Presentation Order:



1. Utility of Lipoarabinomannan as a Marker of NTM Lung Infection in Cystic Fibrosis: Preliminary Results from the Prospective Analysis of urINe LAM to Eliminate NTM Sputum Screening (PAINLESS) Trial – Presented by Jerry Nick

2. Parallel and Distinct Signatures of Adaptation in Pseudomonas aeruginosa Chronic Lung Infections – Presented by Elijah Mehlferber

3. Longitudinal Changes in the Airway Microbiome Following Elexacaftor/Tezacaftor/Ivacaftor Treatment in Cystic Fibrosis – Presented by Anna Hughes

4. Longitudinal Bronchoalveolar Lavage Profiling in Cystic Fibrosis Patients on Elexacaftor/Tezacaftor/Ivacaftor Therapy: A Multi-Modal Analysis – Presented by Eamon Mullen

5. Elevated Airway Glucose in Cystic Fibrosis Promotes Staphylococcus Aureus Adaptation and Antibiotic Resistance – Presented by Megan Kiedwroski